APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perphenazine

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.

Selected research

Market Outlook & Growth Opportunities

Global Perphenazine Market Outlook and Growth Opportunities 2026

9 January 2026197 pages

Choose your research edition.

Industry ResearchPerphenazine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Perphenazine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Perphenazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perphenazine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Perphenazine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.

Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.

North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.

Read the full market overview

In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.

This report provides an overview of the global Perphenazine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Perphenazine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Perphenazine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Perphenazine market size, projected growth trends, production technologies, key applications, and end-use industries.

Perphenazine Segment by Company

Teva

Sandoz

Endo

Mylan

ZHPHARMA

Shandong Boshan Pharma

Perphenazine Segment by Type

Oral Forms

Injectable Solution

Perphenazine Segment by Application

Psychosis

Antiemetic

Perphenazine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Perphenazine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Perphenazine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Perphenazine significant trends, drivers, influence factors in global and regions.

6. To analyze Perphenazine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perphenazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perphenazine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perphenazine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Perphenazine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Perphenazine industry.

Chapter 3: Detailed analysis of Perphenazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Perphenazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Perphenazine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Perphenazine Industry Trends Table 2. Perphenazine Industry Drivers Table 3. Perphenazine Industry Opportunities and Challenges Table 4. Perphenazine Industry Restraints Table 5. Global Perphenazine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Perphenazine Revenue Share by Company (2021-2026) Table 7. Global Perphenazine Sales Volume by Company (K MT) & (2021-2026) Table 8. Global Perphenazine Sales Volume Share by Company (2021-2026) Table 9. Global Perphenazine Average Price (USD/MT) of Company (2021-2026) Table 10. Global Perphenazine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Perphenazine Key Company Manufacturing Base & Headquarters Table 12. Global Perphenazine Company, Product Type & Application Table 13. Global Perphenazine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Perphenazine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Forms Table 18. Significant Companies of Injectable Solution Table 19. Global Perphenazine Sales Volume by Type 2021 VS 2025 VS 2032 (K MT) Table 20. Global Perphenazine Sales Volume by Type (2021-2026) & (K MT) Table 21. Global Perphenazine Sales Volume by Type (2027-2032) & (K MT) Table 22. Global Perphenazine Sales Volume Share by Type (2021-2026) Table 23. Global Perphenazine Sales Volume Share by Type (2027-2032) Table 24. Global Perphenazine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Perphenazine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Perphenazine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Perphenazine Sales Value Share by Type (2021-2026) Table 28. Global Perphenazine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Psychosis Table 30. Significant Companies of Antiemetic Table 31. Global Perphenazine Sales Volume by Application 2021 VS 2025 VS 2032 (K MT) Table 32. Global Perphenazine Sales Volume by Application (2021-2026) & (K MT) Table 33. Global Perphenazine Sales Volume by Application (2027-2032) & (K MT) Table 34. Global Perphenazine Sales Volume Share by Application (2021-2026) Table 35. Global Perphenazine Sales Volume Share by Application (2027-2032) Table 36. Global Perphenazine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Perphenazine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Perphenazine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Perphenazine Sales Value Share by Application (2021-2026) Table 40. Global Perphenazine Sales Value Share by Application (2027-2032) Table 41. Global Perphenazine Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 42. Global Perphenazine Sales by Region (2021-2026) & (K MT) Table 43. Global Perphenazine Sales Market Share by Region (2021-2026) Table 44. Global Perphenazine Sales by Region (2027-2032) & (K MT) Table 45. Global Perphenazine Sales Market Share by Region (2027-2032) Table 46. Global Perphenazine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Perphenazine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Perphenazine Sales Value Share by Region (2021-2026) Table 49. Global Perphenazine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Perphenazine Sales Value Share by Region (2027-2032) Table 51. Global Perphenazine Market Average Price (USD/MT) by Region (2021-2026) Table 52. Global Perphenazine Market Average Price (USD/MT) by Region (2027-2032) Table 53. Global Perphenazine Sales by Country: 2021 VS 2025 VS 2032 (K MT) Table 54. Global Perphenazine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Perphenazine Sales by Country (2021-2026) & (K MT) Table 56. Global Perphenazine Sales Market Share by Country (2021-2026) Table 57. Global Perphenazine Sales by Country (2027-2032) & (K MT) Table 58. Global Perphenazine Sales Market Share by Country (2027-2032) Table 59. Global Perphenazine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Perphenazine Sales Value Market Share by Country (2021-2026) Table 61. Global Perphenazine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Perphenazine Sales Value Market Share by Country (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Perphenazine Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 66. Teva Perphenazine Product Portfolio Table 67. Teva Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Perphenazine Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 71. Sandoz Perphenazine Product Portfolio Table 72. Sandoz Recent Development Table 73. Endo Company Information Table 74. Endo Business Overview Table 75. Endo Perphenazine Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 76. Endo Perphenazine Product Portfolio Table 77. Endo Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Perphenazine Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 81. Mylan Perphenazine Product Portfolio Table 82. Mylan Recent Development Table 83. ZHPHARMA Company Information Table 84. ZHPHARMA Business Overview Table 85. ZHPHARMA Perphenazine Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 86. ZHPHARMA Perphenazine Product Portfolio Table 87. ZHPHARMA Recent Development Table 88. Shandong Boshan Pharma Company Information Table 89. Shandong Boshan Pharma Business Overview Table 90. Shandong Boshan Pharma Perphenazine Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 91. Shandong Boshan Pharma Perphenazine Product Portfolio Table 92. Shandong Boshan Pharma Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Perphenazine Distributors List Table 96. Perphenazine Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Perphenazine Product Image Figure 2. Global Perphenazine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perphenazine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Perphenazine Sales (2021-2032) & (K MT) Figure 5. Global Perphenazine Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Perphenazine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Forms Image Figure 10. Injectable Solution Image Figure 11. Global Perphenazine Sales Volume by Type (2021 VS 2025 VS 2032) & (K MT) Figure 12. Global Perphenazine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Perphenazine Sales Volume Share by Type (2021-2032) Figure 14. Global Perphenazine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Perphenazine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Perphenazine Sales Value Share by Type (2021-2032) Figure 17. Psychosis Image Figure 18. Antiemetic Image Figure 19. Global Perphenazine Sales Volume by Application (2021 VS 2025 VS 2032) & (K MT) Figure 20. Global Perphenazine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Perphenazine Sales Volume Share by Application (2021-2032) Figure 22. Global Perphenazine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Perphenazine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Perphenazine Sales Value Share by Application (2021-2032) Figure 25. Global Perphenazine Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 26. Global Perphenazine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Perphenazine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Perphenazine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Perphenazine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Perphenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Perphenazine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Perphenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Perphenazine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Perphenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Perphenazine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Perphenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Perphenazine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Perphenazine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Perphenazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Perphenazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Perphenazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Perphenazine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Perphenazine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Forms
  • Injectable Solution
Applications
  • Psychosis
  • Antiemetic
Companies covered
  • Teva
  • Sandoz
  • Endo
  • Mylan
  • ZHPHARMA
  • Shandong Boshan Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Perphenazine Sales Value (2021-2032)
  4. 1.2.2 Global Perphenazine Sales Volume (2021-2032)
  5. 1.2.3 Global Perphenazine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Perphenazine Market Dynamics
  1. 2.1 Perphenazine Industry Trends
  2. 2.2 Perphenazine Industry Drivers
  3. 2.3 Perphenazine Industry Opportunities and Challenges
  4. 2.4 Perphenazine Industry Restraints
3 Perphenazine Market by Company
  1. 3.1 Global Perphenazine Company Revenue Ranking in 2025
  2. 3.2 Global Perphenazine Revenue by Company (2021-2026)
  3. 3.3 Global Perphenazine Sales Volume by Company (2021-2026)
  4. 3.4 Global Perphenazine Average Price by Company (2021-2026)
  5. 3.5 Global Perphenazine Company Ranking (2024-2026)
  6. 3.6 Global Perphenazine Company Manufacturing Base and Headquarters
  7. 3.7 Global Perphenazine Company Product Type and Application
  8. 3.8 Global Perphenazine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Perphenazine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Perphenazine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Perphenazine Market by Type
  1. 4.1 Perphenazine Type Introduction
  2. 4.1.1 Oral Forms
  3. 4.1.2 Injectable Solution
  4. 4.2 Global Perphenazine Sales Volume by Type
  5. 4.2.1 Global Perphenazine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Perphenazine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Perphenazine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Perphenazine Sales Value by Type
  9. 4.3.1 Global Perphenazine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Perphenazine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Perphenazine Sales Value Share by Type (2021-2032)
5 Perphenazine Market by Application
  1. 5.1 Perphenazine Application Introduction
  2. 5.1.1 Psychosis
  3. 5.1.2 Antiemetic
  4. 5.2 Global Perphenazine Sales Volume by Application
  5. 5.2.1 Global Perphenazine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Perphenazine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Perphenazine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Perphenazine Sales Value by Application
  9. 5.3.1 Global Perphenazine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Perphenazine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Perphenazine Sales Value Share by Application (2021-2032)
6 Perphenazine Regional Sales and Value Analysis
  1. 6.1 Global Perphenazine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Perphenazine Sales by Region (2021-2032)
  3. 6.2.1 Global Perphenazine Sales by Region: 2021-2026
  4. 6.2.2 Global Perphenazine Sales by Region (2027-2032)
  5. 6.3 Global Perphenazine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Perphenazine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Perphenazine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Perphenazine Sales Value by Region (2027-2032)
  9. 6.5 Global Perphenazine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Perphenazine Sales Value (2021-2032)
  12. 6.6.2 North America Perphenazine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Perphenazine Sales Value (2021-2032)
  15. 6.7.2 Europe Perphenazine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Perphenazine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Perphenazine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Perphenazine Sales Value (2021-2032)
  21. 6.9.2 South America Perphenazine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Perphenazine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Perphenazine Sales Value Share by Country, 2025 VS 2032
7 Perphenazine Country-level Sales and Value Analysis
  1. 7.1 Global Perphenazine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Perphenazine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Perphenazine Sales by Country (2021-2032)
  4. 7.3.1 Global Perphenazine Sales by Country (2021-2026)
  5. 7.3.2 Global Perphenazine Sales by Country (2027-2032)
  6. 7.4 Global Perphenazine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Perphenazine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Perphenazine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Perphenazine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Perphenazine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Perphenazine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Perphenazine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Perphenazine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Perphenazine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Perphenazine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Perphenazine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Perphenazine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Perphenazine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Perphenazine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Perphenazine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Perphenazine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Perphenazine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Perphenazine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Perphenazine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Perphenazine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Perphenazine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Perphenazine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Perphenazine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Perphenazine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Perphenazine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Perphenazine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Perphenazine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Perphenazine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Perphenazine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Perphenazine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Perphenazine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Perphenazine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Perphenazine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Perphenazine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Perphenazine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Perphenazine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Perphenazine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Perphenazine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Perphenazine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Perphenazine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Perphenazine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Perphenazine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Perphenazine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Perphenazine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Perphenazine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Perphenazine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Perphenazine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Perphenazine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Perphenazine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Perphenazine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Perphenazine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Perphenazine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Perphenazine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Perphenazine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Perphenazine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Perphenazine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Perphenazine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Perphenazine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Perphenazine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Perphenazine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Perphenazine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Perphenazine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Perphenazine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Perphenazine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Perphenazine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Perphenazine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Perphenazine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Perphenazine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Perphenazine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Perphenazine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Perphenazine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Perphenazine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Perphenazine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Perphenazine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Perphenazine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Perphenazine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Perphenazine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Perphenazine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Perphenazine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Perphenazine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Perphenazine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Perphenazine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Perphenazine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Perphenazine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Perphenazine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Perphenazine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Perphenazine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Perphenazine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Perphenazine Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Perphenazine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Perphenazine Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Endo
  14. 8.3.1 Endo Company Information
  15. 8.3.2 Endo Business Overview
  16. 8.3.3 Endo Perphenazine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Endo Perphenazine Product Portfolio
  18. 8.3.5 Endo Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Perphenazine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Perphenazine Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 ZHPHARMA
  26. 8.5.1 ZHPHARMA Company Information
  27. 8.5.2 ZHPHARMA Business Overview
  28. 8.5.3 ZHPHARMA Perphenazine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ZHPHARMA Perphenazine Product Portfolio
  30. 8.5.5 ZHPHARMA Recent Developments
  31. 8.6 Shandong Boshan Pharma
  32. 8.6.1 Shandong Boshan Pharma Company Information
  33. 8.6.2 Shandong Boshan Pharma Business Overview
  34. 8.6.3 Shandong Boshan Pharma Perphenazine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Boshan Pharma Perphenazine Product Portfolio
  36. 8.6.5 Shandong Boshan Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Perphenazine Value Chain Analysis
  2. 9.1.1 Perphenazine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Perphenazine Sales Mode & Process
  6. 9.2 Perphenazine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Perphenazine Distributors
  9. 9.2.3 Perphenazine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst